Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Fabrizio FabriziPiergiorgio Messa

Abstract

The management of hepatitis C virus (HCV)-induced glomerular disease remains unsatisfactory despite novel advances in antiviral and immunosuppressive therapy. Recent evidence highlighted the role of ribavirin, a drug provided with immunomodulatory properties, in the treatment of glomerular diseases associated with chronic HCV. We administered low-dose ribavirin (200 mg/day or 200 mg twice a week or 200 mg thrice weekly) in a prospective fashion to a group of patients with HCV-associated glomerular disease (n = 7). Ribavirin monotherapy was given in most (n = 6) patients and was accompanied by erythropoietin therapy in all. The primary endpoint was reduction of 24-h proteinuria after treatment ended; the secondary end-points were decrease in serum creatinine and amelioration of urinary abnormalities. We collected data on on-treatment adverse events (AEs), serious AEs, and laboratory abnormalities. Many patients (n = 6) had inactive HCV infection as they had shown HCV RNA clearance from serum after antiviral therapy with direct-acting antivirals. Some patients (n = 4) had membranoproliferative glomerulo- nephritis, the diagnosis being confirmed by kidney histology in three cases; others (n = 2) received diagnosis of diabetic glom...Continue Reading

References

Aug 27, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F FabriziF Locatelli
Apr 1, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kenji KasunoEri Muso
Jun 28, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Nassim KamarLionel Rostaing
May 12, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bo FengLai Wei
Jan 4, 2012·Annals of Internal Medicine·Olaf M DekkersJan P Vandenbroucke
Jul 20, 2012·The Journal of Infectious Diseases·Mei-Hsuan LeeUNKNOWN R.E.V.E.A.L.-HCV Study Group
Oct 30, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Fabrizio FabriziPatrice Cacoub
Jan 3, 2013·The International Journal of Artificial Organs·Maria Francesca DonatoPiergiorgio Messa
May 22, 2013·Contributions to Nephrology·Sydney C W Tang, Kar Neng Lai
Aug 25, 2015·World Journal of Clinical Cases·Fabrizio FabriziPiergiorgio Messa
Mar 30, 2018·The International Journal of Artificial Organs·Fabrizio FabriziPiergiorgio Messa
Aug 4, 2018·Nature Reviews. Disease Primers·Dario RoccatelloClodoveo Ferri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Pediatrics
D Isaacs
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
B Al Knawy
Revue de l'infirmière
Corinne Taéron
Connecticut Medicine
G Fusco, B Gunderson
© 2021 Meta ULC. All rights reserved